In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hamamatsu Photonics KK

Latest From Hamamatsu Photonics KK

At Astellas R&D Day, Enzalutamide And In-house Tech In The Spotlight

Astellas has tried to build oncology knowhow in the past six years, and while licensed compounds approach approval, Phase II in-house compounds may show whether it can be a global leader.

BioPharmaceutical Japan

Deals Shaping the Medical Industry (03/2009)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions Database, providing comprehensive transaction coverage from 1991 to the present.

Deals Update

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Hamamatsu Photonics KK
  • Senior Management
  • Teruo Hiruma, Chmn. & CEO
  • Contact Info
  • Hamamatsu Photonics KK
    Phone: (81) 53-452-2141
    325-6, Sunayama-cho, Naka-ku
    Hamamatsu City, 430-8587